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ABSTRACT 
GAP JUNCTION COMMUNICATION  
IN MEMORY RETRIEVAL AND EXTINCTION OF COCAINE SEEKING 
 
by  
 
Michael K. Fitzgerald 
 
The University of Wisconsin-Milwaukee, 2016 
Under the Supervision of Devin Mueller 
 
Blocking drug-associated memory retrieval or enhancing extinction of drug-seeking behavior are 
two strategies that could limit relapse in drug addicts. The loci of retrieval and extinction 
memory processes include the prelimbic medial prefrontal cortex and the infralimbic medial 
prefrontal cortex, respectively.  The neurochemical and synaptic mechanisms underlying drug-
related behavior have received considerable attention, but extrasynaptic mechanisms are 
relatively unexplored.  One form of cellular communication, gap junction communication, may 
play a role in drug-related learning and memory.  Gap junction communication between 
neurons and astrocytes provide a cytoplasmic continuity between connected cells and both 
neuronal and astrocytic gap junction communication have been demonstrated to be involved 
with development and maintenance of the CNS, and also aversive and appetitive paradigms of 
learning. However, in retrieval or extinction of drug-seeking behavior, the role of gap junction 
communication is unknown.  Here I describe a series of experiments that investigate astrocytic 
and neuronal gap junction communication in the retrieval and extinction of a cocaine 
conditioned place preference using microinfusions and confocal imaging. 
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Introduction 
  Drug-associated cues can trigger craving and relapse in drug addicts. Preventing retrieval 
of cue-associated memories or reducing cue reactivity through extinction has been 
demonstrated to reduce drug-seeking behavior in various drug-seeking models (LaLumiere et 
al., 2010; Groblewski et al., 2012). Retrieval of a cocaine-associated memory is dependent on 
activation of the prelimbic medial prefrontal cortex (PL-mPFC; Otis et al., 2013) whereas 
extinction of cocaine seeking is consolidated in the infralimbic medial prefrontal cortex (IL-
mPFC; Otis et al., 2014). Although the neurochemical and synaptic mechanisms underlying 
drug-related behavior have been investigated intensively, little is known regarding the 
contribution of neural or astrocytic gap junction communication in the PL-mPFC and IL-mPFC.  
 Both neurons and astrocytes express gap junctions, which are specialized membrane 
structures built of connexin channels that allow cytoplasmic continuity between connected cells 
(Connors & Long, 2004; Pannasch & Rouach, 2013). Neuronal or astrocytic gap junction 
communication can alter neuronal activity and plasticity (Palacios-Prado et al., 2014; Pannasch 
et al., 2011). However, how gap junction communication blockade affects memory retrieval and 
extinction of drug-seeking behavior is not known. Here I describe how gap junction 
communication in the brain plays integral roles in neuronal and astrocytic development, 
maintenance, and ongoing plasticity. Next I describe a series of experiments that were 
performed to investigate gap junction communication in the retrieval and extinction of drug-
seeking behavior using the conditioned place preference (CPP) paradigm and confocal 
microscopy.    
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The conditioned place preference procedure 
 The mechanisms of drug-associated memory retrieval can be investigated using the CPP 
paradigm.  This paradigm is an animal model of drug seeking in which rats learn to associate 
environmental stimuli with cocaine.  During training, rats are given experimenter-delivered 
cocaine or saline followed by exposure to one or another of two chambers.  Following training, 
rats are given full access to both the cocaine- and saline-paired chambers, along with a neutral 
center chamber.  Rats spend more time in the previously cocaine-paired chamber during this 
trial, thus expressing a cocaine-induced CPP (Mueller & Stewart, 2000).  When a CPP is 
expressed, investigators can be certain that the rats acquired, consolidated, and retrieved this 
cocaine-associated memory.  Additionally, rats that express a CPP on additional test trials 
demonstrate that they are subsequently able to retrieve the cocaine-associated memory.  
  
The PL-mPFC and drug-associated memory retrieval  
Recall or retrieval of memory refers to the subsequent re-accessing and behavioral 
expression of previously encoded and stored information.  Studies have demonstrated that 
memory expression can be enhanced by pre-test treatment of nicotine (Faiman et al., 1992), 
cocaine (Rodriguez et al., 1993), or amphetamine (Sara & Deweer, 1982).  These drugs are 
nonspecific, but all of them enhance noradrenergic signaling.  Stimulation of the noradrenergic 
system can influence memory task performance. For example, blockade of α2-adrenergic 
autoreceptors, which normally prevent norepinephrine from being released, leads to an 
increase in rat performance in maze navigation after the task had been forgotten (Sara, 1985; 
Sara & Devauges, 1989).  Moreover, stimulation of the locus coeruleus (LC), a major nucleus of 
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noradrenergic cell bodies (Dahlstroem & Fuxe, 1964), also enhances memory expression after 
forgetting.  This enhancement is prevented by the β-adrenergic receptor (β-AR) antagonist 
propranolol (Devauges & Sara, 1991).  Work from our lab has demonstrated that systemic β-AR 
blockade can prevent retrieval of a cocaine CPP (Otis & Mueller, 2011). Additionally, β-AR 
blockade prevents an increase in neuronal excitability in PL-mPFC neurons (Otis et al., 2013).  
Investigation of the loci of retrieval of a cocaine CPP revealed a role for the PL-mPFC. The PL-
mPFC has previously shown to be necessary for expression of memories and decision making 
(Corcoran and Quirk, 2007; Kim et al., 2013; Euston et al., 2012).  Additionally, glutamatergic 
driven neuronal activity within PL-mPFC has been shown to be necessary for expression of 
innate (Freitas et al., 2013) and learned (Davies et al., 2013; Gilmartin et al., 2013) behaviors.  
Infusions of the AMPA receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) or the 
GluN2B-selective antagonist Ro 25-6981 into PL-mPFC reduced span capacity in rats, a measure 
of working memory.  Furthermore, CNQX or Ro 25-6981 also induced a failure to retrieve the 
correct choice in an appetitive choice task for rats (Davies et al., 2013). Based on these studies 
demonstrating the necessity of PL-mPFC in memory retrieval across tasks, our lab examined the 
effects of microinfusions of non-selective β-AR antagonists into the PL-mPFC in retrieval of a 
cocaine CPP (Otis et al., 2013).  We found that blockade of β-ARs in PL-mPFC impaired retrieval 
of the cocaine CPP.  Thus, the PL-mPFC is necessary for cocaine-associated memory retrieval 
necessary for drug-seeking behavior.   
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The IL-mPFC and extinction of drug seeking  
 Extinction is the reduction in drug seeking across trials when the drug-predictive stimuli 
no longer predict the delivery of a drug reward.  Importantly, extinction is an active learning 
process (Sutton et al., 2003; Knackstedt et al., 2010), is context specific (Bouton et al., 2000, 
2004; Wells et al., 2011) and does not erase the original drug-related memory (Tobena et al, 
1993; Di Ciano & Everitt, 2004).  Rather, extinction learning results in the formation of an 
inhibitory memory that suppresses drug seeking. Extinction of ethanol seeking (Groblewski et 
al., 2012), morphine seeking (He et al., 2011), and cocaine seeking (Otis et al., 2014) is 
consolidated in the IL-mPFC.  Retrieval of the extinction memory is dependent on the IL-mPFC, 
as lesioning of this structure does not disrupt acquisition of extinction within a session, but does 
impair retrieval of the extinction memory when tested in later trials (Quirk et al., 2000).  For 
example, Do-Monte et al. (2015) optogenetically activated or silenced the IL-mPFC during 
extinction training and found that activation reduced the expression of freezing and facilitated 
extinction learning during both the acquisition and retrieval test days. Furthermore, silencing 
the IL-mPFC during extinction training yielded similar results to Quirk et al (2000) where IL-
mPFC silencing did not disrupt acquisition of extinction within the initial session, but did impair 
retrieval of the extinction memory in later trials.  
 So far, I have described how the PL-mPFC and IL-mPFC are involved in the retrieval and 
extinction of drug seeking.  Next, I will describe gap junctions and how they have been 
demonstrated to be involved in drug-seeking behavior.  I will begin with a background of the 
function of gap junctions to show their involvement in development and in different forms of 
plasticity.  
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Gap junctions 
Gap junctions were first detected by electron microscopy in the brains of primates and 
rats. For example, the CA1 and CA3 regions of the hippocampus (Kosaka, 1983), the 
sensorimotor cortex (Sloper and Powell, 1978), and the brainstem and cerebellum all contain 
gap junctions (Sotelo and Korn, 1978). Gap junctions allow intercellular electro- and metabolic-
coupling between adjoining cells and are found in organs and tissues that rely on fast 
intercellular signaling, transfer and communication, including the brain, heart, skin, and inner 
ear. Gap junctions have critical roles in brain development and maturation, and contribute to 
neural precursor cell proliferation, as well as cell migration and differentiation (Bruzzone and 
Dermietzel, 2006). 
Gap junctions are intercellular channels with a diameter of 1.2 nm, and form an aqueous 
pore that penetrates the lipid bilayer of two connected cells.  These channels are formed by two 
hemichannels or connexons, with a connexon contributed by each cell. Connexons are 
composed of six protein subunits called connexins (Kumar and Gilula, 1996).  Gap junctions 
permit the bidirectional diffusion of nutrients, ions, metabolites, and second messengers, 
including potassium, calcium, cyclic adenosine monophosphate (cAMP), inositol 1,4,5-
triphosphate (IP3), cyclic monophosphate, glucose, and other small molecules of about 1000 Da 
or less (Dobrowolski and Willecke, 2009; Zoidl and Dermietzel, 2010).  
Connexin genes and their corresponding proteins are named according to the molecular 
weight of different connexin proteins (e.g., Cx43 has a mass of 43 kilodaltons). The molecular 
topography of connexin proteins include four alpha-helical transmembrane domains, 
intracellular N- and C- termini, two extracellular loops, and a cytoplasmic loop.  There are two to 
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three cysteine residues located in the extracellular loops, which are needed for the proper 
alignment of two connexons to form a continuous gap junction channel (Yeager, 1998).  The 
cytoplasmic C-terminus carries several serine, threonine, and tyrosine residues, which serve as 
targets for a number of protein kinases and phosphatases for posttranslational modifications 
(Solan and Lampe, 2005).  
To date more than 20 different connexin genes have been identified and are expressed 
in many different cells and tissues in mammals (McCracken and Roberts, 2006).  I will focus on 
two, Cx36 and Cx43, as these are the two brain connexins expressed in neurons and astrocytes, 
respectively.  
 
Neuronal gap junction communication  
The combination of in situ hybridization and immunocytochemistry for the neuron-
specific DNA-binding protein NeuN demonstrated that, in rat and human cortices, 
approximately 10% of neurons express Cx36 (Belluardo et al., 1999, 2000; Condorelli et al., 
2000).  Co-localizing Cx36 mRNA with parvalbumin, a GABAergic interneuron marker, confirmed 
that GABAergic inhibitory interneurons express Cx36 (Belluardo et al., 2000).  Furthermore, 
simultaneous recordings revealed that cortical GABAergic interneurons, and not pyramidal cells, 
are interconnected via electrical synapses (Galarreta and Hestrin, 1999; Gibson et al., 1999).  
The gap junctions of inhibitory neurons were shown by ultrastructural studies to be located 
between dendrites, or between dendrites and somata (Szabadics et al., 2001; Tamas et al., 
2000). Cx36 has been thoroughly investigated and has been shown to be selectively expressed 
in neurons and to participate in neuronal gap junctions found in the hippocampus, neocortex, 
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basal ganglia, cerebellum, inferior olive, suprachiasmatic nucleus, pedunculopontine nucleus, 
and the thalamic reticular nucleus (Garcia-Rill et al., 2007; Landisman et al., 2002; McCracken 
and Roberts, 2006; Sohl et al., 2005, 2006). 
The generation of mice with disruption of the Cx36 gene (Gueldenagel et al., 2001; De 
Zeeuw et al., 2003) provided insight and confirmation of the inclusion of Cx36 in the formation 
of gap junctions between inhibitory neurons.  In the Cx36-deficient mice, a gap junction-like 
structure was still observed, but the interneuronal space was reduced to 9 nm.  Dye-coupling 
experiments demonstrated a failure of direct electrical coupling in the Cx36 knockout mice (De 
Zeeuw et al., 2003).  
The availability of Cx36 knockout mice has also allowed for the study of the role of gap 
junctions in learning and memory (Frisch et al., 2005). Allen et al (2011) demonstrated that 
Cx36 knockout mice displayed impaired spatial memory in the open field and in zigzag maze 
running.  Additionally, slower hippocampal theta oscillations were observed in the Cx36 
knockout mice.  The authors theorized that Cx36-coupled interneurons play a functional role in 
spatial coding and cognition (Allen et al., 2011).  A possible explanation for the failure of these 
Cx36 knockout mice to learn could be deficiencies in the mechanisms of long-term potentiation 
(LTP).  The induction of LTP, which is considered a cellular model of learning and memory, is 
impaired in Cx36-deficient animals in the visual cortex (Postma et al., 2011) and the 
hippocampus (Wang and Belousov, 2011).  Interestingly, Wang and Belousov performed a 
western blot analysis of NMDA receptor subunits and found a higher GluN2A/GluN2B ratio in 
Cx36 knockout mice and theorized that there is shift in the threshold for LTP induction in 
knockout animals. Postma et al (2011), however, found equal levels of GluN2A and GluN2B 
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mRNAs in Cx36 knockout animals and controls.  One could argue that deletion of Cx36 would 
have an impact on an animal’s healthy development and subsequent normal function.  
Although Cx36 is expressed early in the development of the embryonic brain (Gulisano et al., 
2000), no developmental or morphological abnormalities were observed by Sohl et al (2004) in 
the neocortex of Cx36-deficient mice.  However, it has also been reported that knockdown of 
Cx36 significantly reduces the number of differentiated neurons and increases the number of 
differentiated astrocytes (Hartfield et al., 2011).  Thus, Cx36 may regulate early neurogenesis 
during development.   
In addition to being able to genetically alter Cx36, pharmaceutical treatment can block 
to block Cx36-containing gap junctions (Juszczak & Swiergiel, 2009).  One compound is the 
antimalarial drug mefloquine (Cruikshank et al., 2004).  Mefloquine has been utilized for local 
microinfusions and has shown to be effective at impairing context-dependent fear learning 
when infused into the dorsal hippocampus in rats prior to or following training (Bissiere et al., 
2011).  Furthermore, unilateral infusion of mefloquine into the ventral hippocampus combined 
with a contralateral infusion into the mPFC decreases anxiety-like behavior on the elevated plus 
maze in mice (Schoenfeld et al., 2014).  However, it should be noted that the dose of 
mefloquine used in these experiments (100 mM) can block astrocyte Cx43 junctions as well 
(Cruikshank et al., 2004). 
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Astrocytic gap junction communication 
In the adult brain, Cx43 is the main connexin spanning the astrocytic gap junction 
network (Yamamoto et al., 1992).  The term astrocyte or “star-like cell” was first used by 
Michael von Lenhossek in 1891 (Lenhossek, 1891).  Astrocytes can have a star-like appearance, 
and express glial fibrillary acidic protein (GFAP), a protein used to identify astrocytes (Tong et al., 
2014).  The list of astrocyte functions is extensive, and is generally focused on maintaining CNS 
homeostasis.  For example, astrocytes form and maintain the blood brain barrier (Abbott, 2005), 
and deletion of Cx43 can weaken the integrity of the blood brain barrier (Ezan et al., 2012).  
Astrocytes have also been shown to be involved in neurogenesis, both pre- and post-natally 
(Alvarez-Buylla et al., 2001). Astrocytes also contribute to morphological homeostasis by 
defining the migration of neural cells during development (Nedergaard et al., 2003), and also 
help regulate synaptogenesis and synaptic pruning to shape the microarchitectural framework 
of gray matter (Pfrieger, 2009).  Astrocytes also help regulate molecular homeostasis by 
regulating the concentrations of ions, neurostransmitters, and neurohormones in the CNS 
(Danbolt, 2001; Newman, 1995) and also detect systemic fluctuations of carbon dioxide, pH, 
sodium, and potassium (Gourine and Kasparov, 2011; Gourine et al., 2010; Huckstepp et al., 
2010; Shimizu et al., 2007).  Astrocytes are also involved with metabolic homeostasis by 
accumulating energy substrates and supplying neurons with lactate (Magistretti, 2006).  
Another role of astrocytes is their defensive protection and structural maintenance of neural 
tissue following trauma or the introduction of pathogens (Pekny and Nilsson, 2005).  
From the aforementioned functions of astrocytes, it is easy to see how involved 
astrocytes are in supporting the cellular and molecular components of neural activity. However, 
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the last fifteen years has seen an explosion of research showing how astrocytes are not only 
directly involved with supporting neural network integrity, but also are directly involved in 
cellular and molecular mechanisms through interactions with neurons to build higher cognitive 
functioning in the brain.  An integral part of this ability is gap junction communication of 
calcium between astrocytes. In 1992, Steven Finkbeiner loaded astrocytes with a calcium-
attaching dye and was able to visualize diffusing calcium moving from one cell to the next in a 
curvilinear pattern (Finkbeiner, 1992).  Astrocytes each contain an endoplasmic reticulum (ER), 
an internal complex that stores calcium concentrations as high as 0.2-1 mM, whereas the 
calcium concentration inside the cytoplasm at baseline is set at about 50-100 nM (Alonso et al., 
1999; Mogami et al., 1998; Solovyova and Verkhratsky, 2002).  ERs each contain ryanodine 
receptors (RyRs) and inositol 1,4,5-triphosphate (IP3)-gated receptors. Activation of either RyR 
or IP3 receptors triggers an ER to release its calcium. RyRs can become activated by calcium 
whereas IP3 receptors can be activated by either calcium or by the second messenger IP3 (IP3 is 
produced by activation of metabotropic receptors linked with phospholipase C) (Bezprozvanny, 
2005).  Hence, astrocytes are capable of calcium-induced calcium release (Verkhratsky and 
Kettenmann, 1996). Finkbeiner (1992) demonstrated that this calcium-induced calcium release 
is possible following glutamatergic activation of metabotropic G-protein coupled receptors that 
are linked to phospholipase C and the second messenger IP3.  Roughly 230 gap junctions connect 
a pair of astrocytes and 50-100 neighboring astrocytes can be influenced by a single calcium 
wave (Innocenti et al., 2000).  Probably the most intriguing aspect of calcium sharing between 
astrocytes is the fact that astrocytes, like neurons, use calcium as a catalyst to release 
transmitters into the extracellular space. In 1994, Parpura and colleagues discovered that 
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astrocytes are capable of releasing glutamate into the extracellular space after a calcium wave 
spreads between astrocytes (Parpura et al., 1994). Additionally, astrocytes release transmitters 
in a calcium-dependent manner involving SNARE protein mediated fusion of vesicles with the 
cell’s plasma membrane (Araque et al., 2000; Zhang et al., 2004).  Furthermore, astrocytes have 
vesicles located in close proximity to synapses that contain different neuroactive 
molecules/transmitters like glutamate, d-serine, ATP, adenosine, GABA, tumor necrosis factor α, 
and prostaglandins (Bezzi et al., 2004, Volterra & Bezzi, 2002). 
The body of work by Finkbeiner and others during the 90’s has stimulated investigation 
of the relationship between neurons and astrocytes in structures throughout the brain.  
Pirttimaki and colleagues (2011) showed that neuronal corticothalamic glutamate release can 
trigger astrocytic calcium waves, and astrocytes can subsequently release glutamate primarily 
targeting NMDA receptors on neurons.  Furthermore, Jourdain and colleagues (2007) studied 
communication between astrocytes and neurons in the hippocampus in the dentate molecular 
layer using a combination of patch-clamp electrophysiology and calcium imaging, and 
demonstrated that glutamate release from astrocytes enhances synaptic strength within the 
surrounding neurons.  By measuring the flow of positively charged ions into the postsynaptic 
neuron, they observed that when astrocytes were stimulated to release a calcium wave, there 
was an increase in neuronal electrical activity as compared to the activity of neurons stimulated 
independently of astrocyte stimulation (Jordain et al., 2007).  
Astrocytes have also been implicated in LTP and long-term depression (LTD). 
Henneberger and his colleagues (2010) investigated the role of astrocytes in LTP at Schaffer 
collateral – CA1 pyramidal cell synapses.  Henneberger and colleagues (2010) observed that 
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holding and preventing elevations of internal calcium levels in astrocytes in the CA1 region 
blocked LTP at excitatory synapses.  Furthermore, they determined that performing a calcium 
clamp on the astrocytes prevented astrocytes from releasing D-serine since LTP blockade could 
be reversed by exogenous application of D-serine (Henneberger et al., 2010).  Regarding LTD, 
Chen’s group (2013) demonstrated that LTD is dependent on calcium elevation in astrocytes 
leading to release of ATP that then acts on P2Y receptors on hippocampal neurons.  Blocking 
P2Y receptors or buffering astrocyte calcium at a low level prevented LTD (Chen et al., 2013). 
So far, I have discussed how neuronal and astrocytic gap junction communication is 
capable of altering neural activity and plasticity, and have provided some examples of how gap 
junction communication is involved in non-addictive behavior. Next, I will focus on data that has 
been collected relating gap junction communication to addictive behaviors. 
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Gap junction communication in reward-seeking and addictive behaviors 
A growing body of literature has emerged investigating gap junction communication in 
relation to addictive behaviors.  Here I describe gap junction involvement in drug-seeking 
behavior within different brain regions during different time points of drug-seeking.    
The ventral tegmental area (VTA) is the beginning of the mesolimbic pathway, which is 
also known as the reward pathway (Kauer, 2004).  The VTA projects to areas such as the nucleus 
accumbens, prefrontal cortex, and amygdala, which interpret environmental stimuli and internal 
states that can affect drug-seeking behavior (Cohen et al., 2012; Schultz, 2006).  Gap junction 
communication can alter behavior associated with activity in the mesolimbic pathway.  For 
example, Lassen and colleagues (2007) systemically injected either the non-selective gap 
junction blocker quinidine or the Cx36-specific blocker mefloquine and found that general and 
Cx36 blockade significantly increased the threshold within the VTA for responding to rewarding 
self-stimulation.  They theorized that VTA gap junction communication blockade reduces the 
rewarding impact of self-stimulation.  It is interesting to note that the animals were still able to 
search out pleasure/rewarding stimuli, but required greater stimulation.  Notably, this study 
involved systemic administration, and the assessment of this data should be taken carefully 
because all regions of the brain were accessed by gap junction antagonists.  
A reduction of pleasure-seeking behavior by gap junction communication blockade also 
occurred in an experimental design reminiscent of Olds and Milner (1954) performed by 
Kokarovtseva and colleagues (2009),  Kokarovtseva et al. trained rats to press a lever to receive 
an electrical current in the hypothalamus. The hypothalamus, particularly the lateral region, 
when stimulated causes pleasure and feelings of reward through glutamatergic projections to 
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the VTA.  After training, the authors microinfused the non-selective gap junction blocker 
carbenoxolone (CBX) into the nucleus accumbens to investigate drug-seeking behavior.  Intra-
accumbens CBX reduced lever-pressing activity. Infusions of tetrodotoxin (TTX) also produced a 
similar decrease in lever-pressing behavior.  Kokarovtseva et al. theorized that blocking gap 
junctions reduces the level of neuronal excitability.  Additionally, as a control, CBX or TTX were 
infused into the motor cortex to examine the function of gap junctions in forelimb motor ability.  
No effect was found, indicating that the effects of CBX and TTX were reward-specific. 
The previous experiments demonstrated that blocking gap junction communication 
following training can decrease drug-seeking behavior.  In animals that have gone through a 
prolonged withdrawal from a drug, an opposite effect is observed. Bull and colleagues (2014) 
investigated gap junction communication in the nucleus accumbens of rats following three 
weeks of withdrawal from ethanol.  They demonstrated that after withdrawal, non-selective or 
astrocytic gap junction blockade caused an increase in lever pressing in ethanol-experienced 
rats compared to controls.  Neuronal gap junction blockade had no effect on lever pressing. 
Additionally, they demonstrated that selective Gαq-DREADDs activation of astrocytic 
intracellular calcium in the nucleus accumbens, decreased lever pressing after three weeks of 
abstinence.  Therefore, astrocytic, but not neuronal, gap junction communication is necessary 
for prevention of drug-seeking behavior following withdrawal.  Astrocytic calcium gap junction 
communication may be needed for decreasing drug-seeking behavior during periods of 
withdrawal within the nucleus accumbens to counter dysregulation of glutamate exchange 
between astrocytes and neurons (Kalivas 2009).  During withdrawal, insertion of calcium-
permeable AMPA receptors into the presynaptic membrane of nucleus accumbens neurons 
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occurs (Wolf & Tseng, 2012), as well as the addition of structural proteins such as actin and 
myosin to form new synapses.  These structural changes increase output from the nucleus 
accumbens and strengthen the drive to drug-seek. 
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Dissertation Goal and Aims 
The PL-mPFC and IL-mPFC underlie drug-associated memory retrieval and extinction of 
drug-seeking behavior, respectively.  Above, I have described how blockade of activity within 
these structures prevents the behavioral expression of drug seeking. Additionally, I have 
described how blockade of gap junction communication prevents behavioral expression of both 
addictive and non-addictive behaviors.  Thus, gap junction communication plays an important 
mechanistic role in memory processing.  
Although gap junction blockade disrupts addictive memories, the specific neuronal or 
astrocytic gap junction communication necessary for retrieval and extinction within the PL-
mPFC and IL-mPFC has remained unexplored.  Therefore, the overall goal of this dissertation 
was to investigate general, neuronal, or astrocytic gap junction communication in the retrieval 
and extinction of a cocaine CPP. This was addressed in the following two aims.  
Aim 1: Determine whether gap junction communication is a mechanism for memory retrieval 
and extinction of a cocaine CPP. Here I evaluated the behavioral effect of blocking general, 
neuronal, or astrocytic gap junction communications within PL-mPFC and IL-mPFC on retrieval 
and extinction of a cocaine CPP. We hypothesized that general or astrocyte specific gap junction 
blockade would prevent a net increase in available transmitter shared at the synapse thereby  
 
Aim 2: Evaluate PL-mPFC astrocytic calcium levels following general, neuronal, or astrocytic 
gap junction communication blockade. Next, using confocal microscopy I determined the 
underlying effects of the gap junction blockers used in Aim 1 on calcium levels in PL-mPFC 
astrocytes.  
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Methods 
Subjects 
Adult male Long-Evans rats weighing 275-300 grams were housed individually 
in clear plastic cages with access to standard laboratory rat chow (Harlan Laboratories) 
and water ad libitum unless otherwise noted.  Rats were maintained on a 14 hour 
light/10 hour dark cycle (lights on at 7am), and were weighed and handled daily. All 
experimental protocols were approved by the Institutional Animal Care and Use 
Committee at the University of Wisconsin-Milwaukee in accordance with National 
Institutes of Health guidelines. 
 
Methods: Aim 1 
Aim 1 was completed to determine the behavioral effect of general, neuronal, or astrocytic gap 
junction communication disruption within the PL-mPFC for retrieval (Aim 1a) and IL-mPFC for 
extinction (Aim 1b) of a cocaine CPP.   
 
Aim 1a: Retrieval of cocaine CPP 
Cannula surgery 
PL-mPFC cannula surgeries were performed to allow PL-mPFC gap junction blockade for 
retrieval of a cocaine CPP.  Rats were anesthetized with ketamine/xylazine (90 mg/kg, 10.5 
mg/kg, i.p.).  Following anesthetization, double-barrel guide cannula (26 gauge; Plastics One, 
Roanoke, VA) were implanted within PL-mPFC (AP, +2.9; ML, ±0.6; DV, -2.9 mm relative to 
bregma).  Cannula were fixed into place with 3 stainless steel skull screws and grip cement. 
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Following surgery, rats were treated with an antibiotic (penicillin g procaine, 75,000 units in 0.25 
ml, s.c.) and an analgesic (carprofen, 5.0 mg in 0.1 ml, s.c.).  Rats were given a minimum of 7 
days for recovery following surgeries, during which behavioral experiments were not  
conducted. Stylets remained within the guide cannula following surgery to maintain patency 
until microinfusions were performed. 
 
Drugs and microinfusions 
For conditioning, cocaine HCl (National Institute on Drug Abuse) was dissolved in sterile 
0.9% saline at a concentration of 10 mg/mL, and administered i.p. at a dose of 10 mg/kg.  PL-
mPFC infusions of vehicle (0.9% saline), the non-selective gap junction blocker carbenoxolone 
(CBX; 50 mM, Tocris), the neuron specific gap junction blocker quinine (100 uM, Tocris), or the 
astrocyte specific gap junction blocker IRL-1620 (0.1 uM, Tocris) were administered at 0.3 μl / 
side over a 2 minute time period. All drugs were dissolved into sterile 0.9% saline. Microinfusion 
injectors were then left in place for a minimum of 1 minute following microinfusions.  Doses of 
each gap junction blocker were based on previous studies (Blomstrand et al., 1999; Cruikshank 
et al., 2004; Sun et al., 2012). 
 
Place conditioning 
Place conditioning and testing was conducted in a 3-chamber apparatus that 
contained 2 distinguishable conditioning chambers (13” x 9” x 11.5”) which were separated 
by a smaller center chamber (6” x 7” x 11.5”).  One of the conditioning chambers had 
wire mesh flooring with white walls, whereas the other conditioning chamber had gold- grated 
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flooring with a black wall.  The smaller center chamber had aluminum sheeting as flooring and 
all white walls.  Each of the larger chambers contained two infrared photobeams separated by 
3”. If the beam furthest from the center chamber was broken, then the rat was determined to 
be in the larger chamber.  If only the beam closest to the center chamber was broken, then the 
rat was determined to be in the center chamber.  In addition, the total numbers of photobeam 
breaks were recorded during microinfusion trials to quantify locomotor activity. 
Baseline preferences were assessed by placing the rats into the center chamber with 
free access to the entire CPP apparatus for 15 minutes.  We previously demonstrated that rats 
spend equivalent time within the larger chambers before conditioning (Otis and Mueller, 2011).  
Thus, following baseline testing, rats were conditioned to associate one chamber, but not 
another, with cocaine in a counterbalanced fashion over 8 days. Injections of saline or cocaine 
were administered immediately before each 20 minute conditioning session, during which rats 
were confined to the appropriate chamber.  Following conditioning, microinfusion adaptation 
was performed by lowering injector tips 1.0 mm past the guide cannula for 2 minutes.  The 
following day, the same procedure took place, except that saline was infused (0.3 μl / side / 2 
min). These procedures allowed for the rats to adapt to mechanical stimulation and changes in 
cranial pressure that occured during microinfusions. 
 
Experimental manipulations 
For retrieval testing, rats were separated into one of four groups.  The vehicle group 
contained control animals that received vehicle (0.9% saline).  Group CBX received the non-
selective gap junction blocker carbenoxolone.  Group IRL-1620 received the astrocyte-specific 
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gap junction blocker IRL-1620. Group Quinine received the neuron-specific gap junction blocker 
quinine. Following conditioning and 10 minutes prior to the first CPP test, all groups received 
their respective drug manipulation.  During the CPP test, all animals had full access to all 
chambers for 15 minutes (Otis et al., 2013).  Additional drug-free daily CPP tests followed to 
determine if gap-junction blockade had any persistent effect on memory retrieval.  Animals 
continued to receive daily drug-free CPP tests until they reached extinction criterion of two 
consecutive days of no significant CPP. 
 
Alternative Strategies Implemented: Aim 1 
As described in the Alternative Strategies portion of the original proposal, different 
possibilities were described as to why the experiments proposed in Aim 1a would result in 
trends, but not significant differences in retrieval disruption.  Significant differences were 
observed within the original experiments proposed in Aim 1a, however additional retrieval 
experiments were performed following completion of the original experiments proposed in Aim 
1a.  
Additional Experiment 1: Restoration of GABAergic tone following neuronal gap junction 
blockade via quinine rescues normal CPP behavior  
Cannula surgery, drugs and microinfusions, place conditioning, and behavioral testing were all 
performed as described above with the exception of quinine (100 uM) and the potent 
GABAA receptor agonist muscimol (0.0001 uM, dose determined by Sajdyk et al., 2008 ) being 
co-infused prior to the first test trial.  
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 Additional Experiment 2: Preventing retrieval of CPP via blockade of astrocyte gap junctions 
with IRL-1620 in addition to blockade of astrocyte hemichannels with Gap19 
Gap junctions as described earlier are formed by two hemichannels contributed by each 
adjacent cell.  However, hemichannels do not always form gap junction channels and have been 
reported to be present in noncontacting membranes of astrocytes to allow intracellular-
extracellular communication (Ye et al., 2003).  These functional hemichannels have been shown 
to release ATP and glutamate (Orellana et al., 2011).  To decrease the net transmitter released 
by astrocytes during retrieval in the PL-mPFC we used the same cannula surgery, drugs, 
microinfusions, and place conditioning as described above with the exception of both Gap19 
(142 uM) and IRL-1620 (0.1uM) being co-infused prior to the first test trial. 
Additional Experiment 3: Preventing retrieval of established CPP via blockade of astrocyte gap 
junctions with IRL-1620 and blockade of astrocyte hemichannels with Gap19 
To test if retrieval of a CPP could be disrupted by Gap19 + IRL-1620 after a CPP had already been 
expressed we used the same cannula surgery, drugs, microinfusions, and place conditioning as 
described above with the exception of both Gap19 (142 uM) and IRL-1620 (0.1uM) being co-
infused prior to the second test trial after a CPP had been established in the first drug-free test 
trial. 
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Aim 1b: Extinction of cocaine CPP 
Cannula surgery 
Cannula surgeries were performed as described above, but double-barrel guide cannula 
(26 gauge; Plastics One, Roanoke, VA) were implanted within IL-mPFC (AP, +2.9; ML, ±0.6; DV, -
4.4 mm relative to bregma).  
Drugs and microinfusions 
For conditioning, cocaine HCl (National Institute on Drug Abuse) was dissolved in sterile 
0.9% saline at a concentration of 10 mg/mL, and administered i.p. at a dose of 10 mg/kg.  IL-
mPFC infusions of vehicle (0.9% saline), the non-selective gap junction blocker CBX (50 mM, 
Tocris), the neuron specific gap junction blocker quinine (100 uM, Tocris), or the astrocyte 
specific gap junction blocker IRL-1620 (0.1 uM, Tocris) were administered at 0.3 μl / side over a 
2 minute time period.  All drugs were dissolved in sterile 0.9% saline. Microinfusion injectors 
were left in place for a minimum of 1 minute following microinfusions. 
Place conditioning 
Place conditioning and testing were conducted as described in Aim 1a.  
Experimental manipulations 
For extinction testing, rats was separated into one of four groups.  The vehicle group 
contained control animals that received vehicle (0.9% saline).  Group CBX received the non-
selective gap junction blocker CBX.  Group IRL-1620 received the astrocyte specific gap junction 
blocker IRL-1620.  Group Quinine received the neuron specific gap junction blocker quinine.  
Following conditioning and 10 minutes prior to the first extinction test, all groups received their 
respective drug manipulation. During the CPP test, all animals had full access to all chambers for 
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30 minutes to accelerate extinction learning (Otis et al., 2014).  Additional drug-free daily 
extinction tests followed to determine if gap-junction blockade had any persistent effect on 
extinction learning.  Animals continued to receive daily drug-free CPP tests until they reached 
an extinction criterion of two consecutive days of no significant CPP. 
 
Behavior data analysis 
 Cocaine seeking was analyzed by comparing time spent between the cocaine, saline, and 
center chambers across trials and between groups using one-way ANOVAs for each individual 
day of testing.  If a significant effect of chamber was found, post-hoc Tukey’s Honestly Significant 
Difference (HSD) tests were used to compare the amount of time spent in the cocaine-paired 
versus the saline-paired chambers during the CPP trial. 
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Methods: Aim 2 
 Aim 2 was completed using confocal microscopy to determine the effects of the gap 
junction blockers used in Aim 1 on PL-mPFC astrocyte cytoplasmic calcium levels.  
 
Tissue preparation and removal for astrocyte identification   
 To image astrocyte morphology in vivo, a single intraperitoneal injection of the 
fluorescent dye sulforhodamine 101 (SR101; 100 mg/kg) was dissolved in saline and 
administered to the animal 40 minutes prior to sacrifice.  Astrocytes have been shown to 
selectively take up SR101 in vivo (Nimmerjahn et al., 2004; Appaix et al., 2012; Perez-Alvarez et 
al, 2013).  Although the mechanism of uptake is still unknown, there is evidence showing that 
metabolites such as glucose and sulforhodamine spread efficiently across astroglial networks 
through gap junctions present in the astrocytic membrane (Rouach et al., 2008).  Astrocyte 
staining were visualized 40–60 min after injection.  
For tissue removal rats were anesthetized with isoflurane, and brains were quickly 
removed and put into ice-cold (0-2°C) oxygenated (95% O2 / 5% CO2) artificial cerebral spinal 
fluid (aCSF) composed of the following (in mM): 124 NaCl, 2.8 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 
CaCl2, 26 NaHCO3, and 20 dextrose.  Coronal slices 300 μm thick containing prefrontal cortex 
were taken using a vibratome (Leica VT1200).  Slices were then allowed recover in continuously 
oxygenated warm aCSF (32°C) for approximately 30 minutes, followed by incubation in 
continuously oxygenated room temperature aCSF for 0.5-8 hours when not in use.   
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Loading of astrocytes with calcium indicator 
To prepare the tissue for calcium visualization within astrocytes, brain slices labeled with 
SR101 were loaded with the fluorescent calcium indicator Fluo-4-AM. Fluo-4-AM was used in 
conjunction with SR101 for calcium imaging of astrocytes (Appaix et al., 2012; Perez-Alvarez et 
al, 2013).  
50 μg of Fluo-4-AM was added to 4.5 μl of fresh dimethyl sulfoxide (DMSO) and 4.5 μl of 
70000 MW of Dextran (to aid in locating the Fluo-4-AM injection site) and was then vortexed 
thoroughly.  Next we loaded a glass pipette with dye solution and lowered it to the surface of 
the slice above this field using a standard microelectrode holder.  We then slowly lowered the 
pipette to approximately 40 μm below the slice surface using a standard micromanipulator 
(Narishige) and applied back pressure to the pipette to eject 2 nl of Fluo-4-AM per injection into 
the PL-mPFC.  To ensure that a large number of astrocytes take up Fluo-4-AM, we injected a 
second and third Fluo-4-AM bolus short distances away, approximately 80-100 μm away from 
the first injection site, and repeated bolus injections at this site.  We then slowly retracted the 
pipette tip from the slice by raising the pipette back to the surface of the slice, made sure that 
the pipette was not clogged, and removed the pipette.  We then allowed 30 min before imaging 
for the astrocytes to take up the dye and for the background signal to diminish.  
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Experimental manipulations 
 Tissue slices loaded with SR101 and Fluo-4-AM were then separated into one of eight 
groups: 
1. Control (no gap junction blockade treatment) 
2. Treatment with 100 μM CBX for 5 min prior to scan 
3. Treatment with 0.1 μM IRL-1620 for 5 min prior to scan 
4. Treatment with 100 μM Quinine for 5 min prior to scan 
5. Treatment with 100 μM Norepinephrine (NE) for 2 min prior to scan 
6. Treatment with 100 μM CBX for 5 min then with 100 μM NE for 2 min prior to scan 
7. Treatment with 0.1 μM IRL-1620 for 5 min then with 100 μM NE for 2 min prior to scan 
8. Treatment with 100 μM Quinine for 5 min then with 100 μM NE for 2 min prior to scan 
NE can evoke calcium-induced calcium sharing between astrocytes (Salm & McCarthy, 1990; 
Duffy & MacVica, 1995).  All drugs were mixed into aCSF.  
 
Confocal microscopy, recording astrocytic calcium activity  
PL-mPFC Fluo-4-AM injection sites were visualized with differential interference contrast 
using a 60X water-immersion lens mounted on an Nikon C2 Scanning Confocal microscope 
(Nikon Instruments).  To set up the confocal microscope for imaging, we set the default values 
for each laser to a high photomultiplier setting, 1x gain and 0.5% laser output power.  We also 
applied a 1.5x zoom for better visualization of astrocytes.  Next we set the field resolution to 
512 x 512 pixels. SR101-fluorescence was detected through a bandpass filter of 503-548 nm for 
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the 488 nm laser. Fluo-4-AM-fluorescence was detected through a bandpass filter of 624-724 
nm for the 559 nm laser (see Figure 6). 
To record astrocyte calcium activity we drew boxes using the image acquisition NIS 
Elements Imaging Software over regions of interest (ROIs) within the cell, in this case over 
astrocyte cell bodies.  We then recorded fluorescence over time from the ROI.  Any increases in 
fluorescence over baseline indicated increases in cytoplasmic calcium concentration (Takahashi 
et al., 1999).  Tissue was scanned 200 times with each scan lasting 4.5 seconds over the course 
of 15 minutes.  Each individual scan measured and averaged the highest and lowest intensity of 
Fluo-4-AM intensity (mean intensity).  We also subtracted away background fluorescence from 
our ROI fluorescent value for each scan. The mean intensity value of each scan was taken for 
analysis.  
Analysis of astrocyte calcium activity 
 Since Fluo-4-AM naturally decays during exposure to the confocal laser, the mean 
intensity of each scan was compared to the initial scan. To normalize the data the initial scan 
mean was assigned the starting value of 100 and each subsequent scans value was calculated 
relative to the initial scan’s value of 100.  For example, if during the initial scan the mean 
intensity was 851.36 and received the starting value of 100, the second scan with a mean 
intensity of 848.85 was receive a value of 99.71.  Use of these calculations allowed all the 
different cells in the same treatment groups to be collectively analyzed and plotted over the 
course of the 200 scans.  Plotting data this way allowed a polynomial curve to be established for 
each tissue slice.  Next, using the Riemann sum formula (B1+B2)/2*(A2-A1) we were able to 
calculate the total area under the curve to provide a measure of the total amount of calcium 
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fluoresced over the entire 200 scans.  Using Riemann sum formula for example, if B1 represents 
scan number 1, B2 is scan number 2, A2 is mean intensity value of scan 2, and A1 is the mean 
intensity value scan 1.  You then continue to reapply this equation and subsequently B1 then 
represents the x-axis value of scan number 2, B2 is the x-axis value of scan number 3, A2 is 
mean intensity value of scan 3, and A1 is the mean intensity value scan 2.  We repeated this 
area under the curve equation for all 200 scans to establish a relative overall intensity value for 
each scan.  Finally, using ANOVA we were able to compare total areas under each curve for 
each treatment group. If a significant effect was found, post-hoc Tukey’s Honestly Significant 
Difference (HSD) tests will be used to identify which individual treatment group significantly 
differed from another.  
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Results 
Aim 1 
Memory retrieval of conditioned place preference 
Following conditioning, rats were given 15 minute CPP trials across days to examine both 
retrieval and retention of a cocaine-associated memory. We hypothesized that general gap 
junction or astrocytic gap junction blockade would prevent retrieval whereas neuronal gap 
junction blockade would not. PL-mPFC infusions (Figure 1) of vehicle, CBX (50 mM), IRL-1620 (.1 
uM), or quinine (100 uM) were administered prior to the first trial. PL-mPFC CBX or IRL-1620 
prevented CPP expression on the first and subsequent infusion-free trials whereas quinine 
prolonged CPP expression trials (Figure 1). Repeated measures ANOVA revealed a significant 
effect of chamber for vehicle (F2,22=30.14, p<0.05), carbenoxolone (F2,20=20.70, p<0.05), IRL-
1620 (F2,18=29.37, p<0.05), and quinine treatment (F2,18=23.06, p<0.05).  Post hoc analyses 
confirmed that vehicle, IRL-1620-treated, and quinine-treated groups expressed a CPP during 
the first trial (p < 0.05), whereas the CBX-treated group did not (p > 0.05).  On subsequent test 
trials 2 and 3, vehicle and quinine-treated groups continued to express a CPP (p < 0.05), 
whereas the CBX-treated group continued to express a CPP deficit (p > 0.05). Moreover, the IRL-
1620-treated group began to demonstrate a CPP deficit across trials (p > 0.05).  Overall, these 
data demonstrate that general and astrocyte-specific gap junction blockade prevents retrieval of 
a CPP, an effect that persists even in the absence of additional treatment.  
On trial 4, the vehicle, CBX-treated, and IRL-1620-treated groups expressed a CPP deficit 
(p > 0.05) whereas the quinine-treated group continued to express a CPP (p < 0.05).  Thus, 
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neuron-specific gap junction blockade in the PL-mPFC prolongs CPP expression. Additionally, 
during test trials 5 and 6, the quinine-treated group continued to express a CPP (p < 0.05), 
whereas the vehicle-treated group did not, thus further demonstrating that neuron-specific gap 
junction blockade in the PL-mPFC prolongs CPP expression.  For the CBX-treated and IRL-1620 
treated groups in test trials 5 and 6, a weak but significant CPP re-emerged (p < 0.05), 
suggesting that the CPP deficit in previous trials was somewhat transient. 
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Figure 1. PL-mPFC blockade of general or astrocyte-specific gap junctions prevent extinction of a 
cocaine-CPP. Left, Coronal drawings showing injector tip placements for vehicle (n = 11), CBX 
(n = 10), IRL-1620 (n = 9), and quinine (n = 10). White circle represents Vehicle, black circles 
represent experimental groups. Right, IL-mPFC infusions (arrows) of CBX or IRL-1620 but not 
quinine before the first CPP trial prevented extinction of the CPP. **p < 0.01, *p < 0.05. Error 
bars indicate SEM. 
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Following the observation that neuron-specific gap junction blockade with quinine in the 
PL-mPFC prolonged CPP expression across days, we hypothesized that a reintroduction of 
GABAergic tone would oppose this effect and promote extinction.  Following conditioning, rats 
were given 15 minute trials to test for CPP expression across days. As predicted, animals that 
received a PL-mPFC infusion of both the neuron-specific gap junction blocker quinine (100 uM) 
and the potent GABAA receptor agonist muscimol (.0001 uM) prior to the first trial showed 
similar drug-seeking and extinction behavior as control animals (Figure 3).  Repeated measures 
ANOVA revealed a significant effect of chamber for vehicle (F2,20=34.71, p<0.05) and quinine + 
muscimol groups (F2,18=29.95.06, p<0.05).  Post hoc analyses confirmed that vehicle and quinine 
+ muscimol-treated groups expressed a CPP during the first, second, and third trial (p < 0.05), 
but not during the fourth, fifth, and sixth trial (p > 0.05).  Thus, restoring GABAergic tone in the 
presence of neuron-specific gap junction blockade in the PL-mPFC restores normal drug-seeking 
behavior and extinction of the CPP. 
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Figure 2. PL-mPFC infusion of both neuron-specific gap junction blocker quinine and 
GABAA receptor agonist muscimol restores normal drug-seeking behavior and extinction of the 
CPP. Left, Coronal drawings showing injector tip placements for vehicle (n = 10) and quinine + 
muscimol (n = 9). White circle represents Vehicle, black circles represent experimental groups. 
Right, PL-mPFC infusions (arrows) of vehicle or quinine + muscimol before the first CPP trial 
resulted in similar retrieval and extinction of the CPP. ***p < 0.001, **p < 0.01, *p < 0.05. Error 
bars indicate SEM. 
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Gap junctions are formed by two hemichannels contributed by each adjacent cell.  
However, hemichannels do not always form gap junction channels and have been reported to 
be present in noncontacting membranes of astrocytes to allow intracellular-extracellular 
communication (Ye et al., 2003).  These functional unopposed hemichannels have been shown 
to release ATP and glutamate (Orellana et al., 2011).  Thus, we investigated if unopposed 
hemichannels affected drug-seeking behavior either independently or in conjunction with 
astrocyte-specific gap junctions.  We hypothesized that animals receiving the unopposed 
hemichannel blocker Gap19 would show similar retrieval blockade as the IRL-1620 animals from 
the second experiment (see Figure 2) and animals receiving both Gap19 and IRL-1620 would 
demonstrate a more persistent retrieval blockade than either group of animals independently 
treated with Gap19 or IRL-1620. 
Following conditioning, rats were given 15 minute trials to test for CPP expression across 
days.  Animals that received a PL-mPFC infusion of the unopposed hemichannel blocker Gap19 
(142 uM) alone prior to the first trial showed weaker but longer-lasting CPP expression across 
days.  Animals that received a PL-mPFC infusion of both Gap19 (142 uM) and IRL-1620 (0.1uM) 
showed a lack of CPP expression across days (Figure 4).  Repeated measures ANOVA revealed a 
significant effect of chamber for the vehicle (F2,20=34.22, p<0.05), Gap19 (F2,22=43.31, p<0.05), 
and Gap19 + IRL-1620 groups (F2,22=43.31, p<0.05).  Post hoc analyses confirmed that both the 
vehicle and Gap19 groups expressed a CPP during the first trial (p < 0.05).  The vehicle group 
then continued to express a CPP during the second and third trial (p < 0.05), but not during the 
fourth, fifth, and sixth trial (p > 0.05).  The Gap19 group continued to show a CPP during trial 
three and trial five (p < 0.05), but during trial two and trial four did not (p > 0.05).  The Gap19 + 
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IRL-1620 group did not express CPP on any trial, and post hoc analyses confirmed no 
significance in time spent between the cocaine-paired and saline-paired chamber (p > 0.05).  
Thus, blockade of either astrocyte-specific gap junctions (Figure 2) or astrocyte unopposed 
hemichannels in the PL-mPFC does not prevent initial retrieval of a CPP, but impairs subsequent 
CPP expression across days. Joint blockade of both astrocyte unopposed hemichannels and 
astrocyte-specific gap junctions in the PL-mPFC persistently blocks CPP expression.  
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Figure 3. PL-mPFC infusion of both unopposed hemichannel blocker Gap19 and astrocyte-
specific gap junction blocker IRL-1620 persistently disrupts retrieval of CPP. Left, Coronal 
drawings showing injector tip placements for vehicle (n = 10), Gap19 (n = 11), and Gap19 + Irl-
1620 treated animals (n = 11). White circle represents Vehicle, black circles represent 
experimental groups. Right, PL-mPFC infusions (arrows) of Gap19 + Irl-1620 before the first CPP 
trial persistently disrupts retrieval of CPP whereas infusions of vehicle or Gap19 does not.  **p < 
0.01, *p < 0.05. Error bars indicate SEM. 
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To test if retrieval of a CPP could be disrupted by Gap19 + IRL-1620 after a CPP had 
already been expressed, we next examined the effect of Gap19 + IRL-1620 on retrieval by 
microinfusion prior to the second trial after a CPP had already been expressed.  Following 
conditioning, all rats expressed a CPP for the previously cocaine-paired chamber during the first 
trial. PL-mPFC microinfusions of Gap19 + IRL-1620 (n=11), but not vehicle (n=9) before the 
second trial impaired expression of the CPP on that trial and all subsequent trials (Figure 5).  
Repeated measures ANOVA revealed an effect of chamber for both groups during the first trial 
(vehicle F2,22=24.07, p<0.05; Gap19 + IRL-1620, F2,18=19.27, p<0.05), and post hoc analyses 
confirmed that both groups spent significantly more time in the cocaine-paired chamber than 
the saline-paired chamber (p<0.05).  Following microinfusion of Gap19 + IRL-1620 or vehicle 
prior to the second trial, only the vehicle-treated rats spent significantly more time in the 
previously cocaine-paired chamber (effect of chamber: F2,22=16.44, p<0.05, post hoc p<0.05), 
whereas Gap19 + IRL-1620-treated rats spent an equivalent amount of time in all chambers 
(F2,18=4.11, p>0.05).  On subsequent infusion-free trials, vehicle-treated rats continued to spend 
significantly more time in the cocaine-paired chamber overall (effect of chamber: 
F2,22=7.61, p<0.05, post hoc p<0.05), whereas Gap19 + IRL-1620-treated rats spent an equivalent 
amount of time in all chambers (F2,18=1.18, p>0.05).  Therefore, Gap19 + IRL-1620 infusions into 
PL-mPFC disrupted the retrieval of a previously expressed CPP. 
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Figure 4. PL-mPFC infusion of both unopposed hemichannel blocker Gap19 and astrocyte-
specific gap junction blocker IRL-1620 disrupts retrieval of an established CPP. Left, Coronal 
drawings showing injector tip placements for vehicle (n = 9), Gap19 + IRL-1620 treated animals 
(n = 11). White circle represents Vehicle, black circles represent experimental groups.  Right, all 
rats expressed a CPP for the previously cocaine-paired chamber over the previously saline-
paired chamber during the first test trial. PL-mPFC infusions (arrows) of Gap19 + IRL-1620 but 
not vehicle before the second CPP trial prevented rats from expressing a CPP during the second 
trial and subsequent trials. ***p < 0.001, **p < 0.01, *p < 0.05. Error bars indicate SEM. 
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Extinction of conditioned place preference  
Following conditioning, rats were given longer 30 minute CPP trials that has been shown 
to promote extinction learning (Otis et al., 2014).  We hypothesized that general gap junction or 
astrocytic gap junction blockade would prevent extinction whereas neuronal gap junction 
blockade would not.  IL-mPFC infusions (Figure 1) of vehicle, CBX (50 mM), IRL-1620 (.1 uM), or 
quinine (100 uM) were administered prior to the first trial. IL-mPFC carbenoxolone or IRL-1620 
impaired extinction across days (Figure 5).  Repeated measures ANOVA revealed a significant 
effect of chamber for the vehicle (F2,22=18.45, p<0.05), carbenoxolone (F2,20=14.635, p<0.05), 
IRL-1620 (F2,20=11.78, p<0.05), and quinine groups (F2,20=17.39, p<0.05).  Post hoc analyses 
confirmed that all groups expressed a CPP during the first trial (p < 0.05). However, only 
carbenoxolone-treated and IRL-1620-treated rats expressed a CPP during subsequent trials (i.e., 
trials 2-4; p < 0.05), whereas vehicle-treated and quinine-treated rats did not (p > 0.05).  Thus, 
IL-mPFC general or astrocyte specific gap junction blockade impaired extinction of the CPP. 
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Figure 5. IL-mPFC blockade of general or astrocyte-specific gap junctions prevent extinction of a 
cocaine-CPP. Left, Coronal drawings showing injector tip placements for vehicle (n = 11), CBX 
(n = 10), IRL-1620 (n = 9), and quinine (n = 10). White circle represents Vehicle, black circles 
represent experimental groups.  Right, IL-mPFC infusions (arrows) of CBX or IRL-1620 but not 
quinine before the first CPP trial prevented extinction of the CPP. **p < 0.01, *p < 0.05. Error 
bars indicate SEM. 
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Aim 2 
 
PL-mPFC astrocytic calcium levels following general, neuronal, or astrocytic gap junction 
communication blockade was next investigated.  Following tissue removal and preparation of 
SR-101 and Fluo-4-AM (Figure 6), PL-mPFC tissue was treated with one of the following 
treatments: 
1. Control (no gap junction blockade treatment) - 6 animals, 7 slices, 26 cells. 
2. Treatment with 100 μM for 5 min prior to scan - 6 animals, 6 slices, 21 cells. 
3. Treatment with 0.1 μM IRL-1620 for 5 min prior to scan - 6 animals, 6 slices, 22 cells. 
4. Treatment with 100 μM Quinine for 5 min prior to scan - 6 animals, 6 slices, 20 cells. 
 
NE has previously been shown to evoke calcium-induced calcium sharing between 
astrocytes (Salm & McCarthy, 1990; Duffy & MacVica, 1995).  So we also tested to see if various 
gap junction blockade treatments would prevent NE evoked calcium-induced calcium rise in 
astrocytes. 
5. Treatment with 100 μM NE for 2 min prior to scan - 6 animals, 6 slices, 25 cells. 
6. Treatment with 100 μM CBX for 5 min then with 100 μM NE for 2 min prior to scan - 6 animals, 
6 slices, 18 cells. 
7. Treatment with 0.1 μM IRL-1620 for 5 min then with 100 μM NE for 2 min prior to scan - 6 
animals, 6 slices, 18 cells. 
8. Treatment with 100 μM Quinine for 5 min then with 100 μM NE for 2 min prior to scan - 6 
animals, 6 slices, 16 cells. 
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Following tissue removal, slices containing the PL-mPFC were prepared as described 
above. We hypothesized neuronal gap junction blockade or NE treatment would increase PL-
mPFC basal astrocyte cytoplasmic calcium levels whereas general gap junction or astrocytic gap 
junction blockade would not. Additionally, we hypothesized that tissue receiving NE treatment 
after neuronal gap junction blockade would increase PL-mPFC astrocyte cytoplasmic calcium 
levels whereas NE treatment after general gap junction blockade or astrocytic gap junction 
blockade would not. We observed that bath application of NE (Figure 7) or quinine (Figure 10) 
increased PL-mPFC basal astrocyte cytoplasmic calcium levels whereas bath application of CBX 
(Figure 8), or IRL-1620 (Figure 9) had no effect on PL-mPFC basal astrocyte cytoplasmic calcium 
levels. Additionally, CBX (Figure 11) or IRL-1620 (Figure 12) treatment prevented NE from 
increasing PL-mPFC astrocyte cytoplasmic calcium levels, whereas quinine (Figure 13) did not. 
ANOVA revealed an overall effect of group (F7,164=3.46, p<0.05) and post hoc analyses confirmed 
that the area under the curve (AUC) for the control group was significantly lower than the NE 
group AUC (ps<0.05), the quinine group AUC (ps<0.05), and the quinine + NE group AUC 
(ps<0.05).  Thus, NE or neuronal gap junction blockade via quinine increases cytoplasmic 
calcium levels in astrocytes. Additionally, the IRL 1620 + NE group AUC was significantly lower 
than the NE group AUC (ps<0.05). Thus, astrocyte-specific gap junction blockade via IRL-1620 
prevented the NE-induced increase of calcium levels. Overall, NE or neuronal gap junction 
blockade increases basal cytoplasmic calcium levels in PL-mPFC astrocytes and blocking 
astrocyte gap junctions can prevent NE-induced calcium level increases. 
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Figure 6. Imaging of PL-mPFC astrocytes using confocal microscopy.                                                              
Top left, At 40x magnification, astrocyte cell bodies were identified in red using SR-101 staining.     
Top right, Fluo-4-AM staining in green identified calcium.                            
Bottom left, Merged images show that Fluo-4-AM staining of calcium is co-localized within 
astrocyte cell bodies. 
Bottom right, Example ROI collection. 
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Discussion 
These studies aimed (1) to determine whether gap junction communication is a 
mechanism for memory retrieval and extinction of a cocaine CPP and (2) to evaluate PL-mPFC 
astrocytic calcium levels following general, neuronal, or astrocytic gap junction communication 
blockade.  
Results revealed that, within the PL-mPFC, general and astrocyte-specific gap junction 
blockade prevent retrieval of a CPP whereas neuronal-specific gap junction blockade prolonged 
drug-seeking behavior.  Additional behavioral experiments within the PL-mPFC revealed that 
restoring GABAergic tone in conjunction with blockade of neuronal-specific gap junctions 
restored normal memory retrieval and extinction of a CPP.  Furthermore, blocking unopposed 
astrocyte hemichannels in conjunction with astrocyte-specific gap junctions prevented initial 
and subsequent memory retrieval of a CPP, whereas blockade of just astrocyte gap junction or 
just unopposed astrocyte hemichannels did not.  Additionally, blocking PL-mPFC unopposed 
astrocyte hemichannels in conjunction with astrocyte-specific gap junctions prevented memory 
retrieval of a CPP after a CPP had been established.  Finally within aim 1, blockade of IL-mPFC 
general and astrocyte-specific, gap junctions prevented extinction of a CPP.   
In Aim 2, I examined the effects of the various gap junction blockers on calcium 
dynamics in PL-mPFC.  Neuronal-specific gap junction blockade increased cytoplasmic calcium 
levels in astrocytes, whereas astrocyte-specific gap junction blockade did not.  Furthermore, NE 
exposure induced an increase in cytoplasmic calcium levels in astrocytes, but pre-application of 
an astrocyte-specific gap junction blocker prevented the NE-induced rise.  In contrast, neuron-
specific gap junction blockade did not prevent the NE-induced rise in calcium levels in 
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astrocytes.  Taken together, astrocyte and neuronal gap junctions play differential roles in 
memory retrieval and extinction of a CPP and have opposing effects on basal and NE-induced 
calcium levels in PL-mPFC astrocytes.   
 
Aim 1 
 Data revealed that blocking PL-mPFC astrocyte specific gap junctions and unopposed 
hemichannels prevented memory retrieval of a CPP both during the initial and subsequent test 
trials.  Furthermore, data revealed that blocking PL-mPFC astrocyte specific gap junctions and 
unopposed hemichannels prevented memory retrieval of a CPP after a CPP had been 
established.  Previous data has shown that astrocyte gap junction communication influences 
neural activity (Parri et al., 2001). Additionally, blocking unopposed hemichannels in astrocytes 
decreases the release of glutamate and ATP (Ye et al., 2003) and decreases CA1 pyramidal 
neurons EPSC amplitudes in mice (Chever et al., 2014).  Our data further revealed that blockade 
of astrocyte gap junctions alone or unopposed astrocyte hemichannels alone did not prevent 
initial memory retrieval, but did prevent subsequent retrieval of a CPP.  Additionally, a return of 
a CPP was observed on test trial 6 for the astrocyte gap junction blockade animals even though 
during test trials 2-5, a CPP was not expressed.  Overall, our data support that astrocytes can 
communicate to other astrocytes and neurons to mediate cocaine-associated memory retrieval 
in PL-MFC. In fact, these data are the first to demonstrate that blocking both PL-mPFC astrocyte 
gap junction communication and unopposed astrocyte hemichannels can persistently prevent 
memory retrieval of a drug-associated memory.  Further investigation is necessary to determine 
the specific transmitters being released by astrocytes to neurons within the PL-mPFC to allow 
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memory retrieval to occur and what short and long term plasticity events can occur to cause a 
return of CPP expression following gap junction blockade.  
 PL-mPFC neuron-specific gap junction blockade prolonged drug-seeking behavior as 
compared to vehicle control.  Restoring PL-mPFC GABAergic tone in conjunction with blocking 
neuron-specific gap junctions restored animals to normal drug-seeking behavior comparable to 
controls.  Previous work has shown that GABAergic inhibitory interneurons selectively express 
Cx36 (Belluardo et al., 2000).  The application of quinine selectively blocks Cx36 (Cruikshank et 
al., 2004) and has been shown to increase spike frequency in CA3 recordings of guinea pig tissue 
slices (Yoshida et al., 1986). The authors proposed that quinine’s mechanism of action on neural 
activity was through blockade of an after-hyperpolarizing potassium channel (Yoshida et al., 
1986).  Overall, our data support the conclusion that blocking Cx36 in inhibitory interneurons 
leads to a decrease of inhibitory signal in local circuitry and a net increase in activity within a 
structural region of the brain.  
 PL-mPFC non-specific gap junction blockade prevented memory retrieval of a CPP on 
test trials 1-4, but caused a return of preference on test trials 5-6.  These data may be 
anomalous, or they may reflect the combined effects of astrocyte and neuron specific gap 
junction blockade.  The initial trials appear similar to those from the IRL-1620 group, whereas 
later trials appear similar to those from the quinine group during which the preference returns 
even after the control animals have extinguished their drug-seeking behavior.  CBX has been 
one of the most widely used non-selective gap junction blockers (Moradi et al., 2013; Chepkova 
et al., 2008; Schoenfeld et al., 2014) and has been shown to reduce neural activity (Tover et al., 
2009) impair LTP (Chepkova et al., 2008), and decrease diffusion of gap junction channel-
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permeable dye between astrocytes (Sun et al., 2012).  No other data are currently available 
showing the long-lasting effect of CBX on neuron or astrocyte activity, but CBX can washout 
during electrophysiological recordings after 30 min (Alvarex-Maubecin et al., 2000).  
Interestingly, it has been observed that CBX blocks unopposed astrocyte hemichannels in 
addition to being a non-selective gap junction blocker (Ye et al., 2003).  Thus, further study of 
CBX’s dynamics will be needed to determine the extent of effects on both neurons and 
astrocytes.  
 Results revealed that general or astrocyte-specific gap junction blockade in IL-mPFC 
prevented extinction learning whereas neuron-specific gap junction blockade accelerated 
extinction learning.  These results are similar to those found in the PL-mPFC behavioral studies, 
where general and astrocyte-specific gap junction blockade prevented the function of the PL-
mPFC whereas neuron specific gap junction blockade accelerated and had the opposite effect 
on the PL-mPFC.  Taken together, drug-associated retrieval and extinction memories can be 
impaired or strengthened by blocking specific gap junction activities, with astrocyte and 
neuronal gap junctions serving opposing roles in regions of the brain involved in memory 
retrieval and extinction of drug-seeking behavior. 
 
Aim 2 
Our data revealed that astrocyte gap junction blockade prevented a NE-induced increase 
in cytoplasmic calcium levels in astrocytes. NE can evoke a calcium increase within astrocytes 
(Salm & McCarthy, 1990).  In the absence of provoking conditions, spontaneous calcium activity 
in individual astrocytes does not spread among astrocytes as an intercellular calcium wave (Nett 
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et al.2002).  In baseline conditions, the magnitude of correlated activity in nearby and distant 
astrocytes is quite similar (Hirase et al., 2004). 
Gap junction blockade does not render an astrocyte unable to release transmitter, which 
could explain why PL-mPFC IRL-1620 treated animals in aim 1 showed a significant preference 
on day 1 of testing.  Calcium and cAMP are active in SNARE-dependent merger of vesicles 
(Vardjan & Zorec, 2015) and calcium increases in a single astrocyte can lead to the release of 
transmitters like glutamate and ATP (Parpura et al., 1994).  Thus, for a single astrocyte to release 
its own transmitter, gap junction communication is not always necessary.  However, when gap 
junctions between astrocytes are open, calcium waves between astrocytes can lead to a much 
more unified release of transmitter from an ensemble of astrocytes that can then communicate 
to other nearby astrocytes and neurons.  For example, glutamate can induce astrocytic calcium 
waves (Innocenti et al., 2000) in addition to causing a calcium rise inside a single astrocyte.  
Once calcium waves begin, they can exhibit oscillatory behavior that can persist for periods of 
5–30 min at variable frequencies (10–110 mHz).  A direct correlation between glutamate 
concentration and the frequency of oscillations has also been observed. At low concentrations 
(below 1 μM), intracellular calcium transients are asynchronous and localized.  In contrast, at 
higher concentrations of glutamate (10–100 μM), calcium waves propagate over longer 
distances (Cornell-Bell et al., 1990).  Additionally, rhythmic oscillatory calcium waves can release 
trasnmitters in a unified manner that affect the local field potentials of neurons (Tewari & 
Parpura, 2015).  IRL-1620 decreases calcium wave propogation by roughly 80-90 percent in 
hippocampal and striatal astrocytes (Blomstrand et al., 1999).  Taken together our data suggests 
that blocking astrocyte gap junction communication with IRL-1620 prevents NE-induced 
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oscillatory actions of calcium waves (Paukert et al., 2014; Salm & McCarthy, 1990). 
Because the astrocytic release of transmitters is slower than neuron communication, 
some theorize that the astrocytic system regulates homeostatic processes.  Astrocytic 
transmission thus models the endocrine system in that it is slower than the neuronal 
transmission but more widespread.  For example, when astrocytes connected to arterioles elicit 
calcium waves, there is an increase in the release of vasoactive compounds (Bezzi et al. 
1998).  This work supports the idea that astrocytes function to regulate local circulation 
according to the metabolic needs of neurons. 
PL-mPFC tissue exposed to the neuron-specific gap junction blocker quinine significantly 
increased cystolic calcium in astrocytes.  Our data from aim 1 revealed that increasing 
GABAergic tone within the PL-mPFC counteracts quinine’s effect of prolonging drug-seeking 
behavior.  These data offer evidence that a decrease in GABAergic tone on pyramidal neurons 
cause an increase in neuronal transmitter reléase that can trigger astrocytic calcium waves.  
Furthermore, co-localizing Cx36 mRNA with parvalbumin, a GABAergic interneuron marker, 
shows that GABAergic inhibitory interneurons express Cx36 (Belluardo et al., 2000) and quinine 
specifically blocks channel conductance of Cx36 (Cruikshank et al., 2004).  Other data suggest 
that quinine may have another mechanism to increase neuronal excitability.  Quinine increases 
the excitability of CA3 pyramidal neurons, possibly through blockade of an AHP – K+ channel 
(Yoshida et al., 1986).  This proposed mechanism is activated by protein kinase A (PKA; Liu et al. 
1999) and PKA is able to regulate AMPA receptor recruitment to the plasma membrane (Gomes 
et al., 2004) to further increase neuronal excitability.  
PL-mPFC tissue exposed to the general gap junction blocker CBX did not significantly 
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decrease cystolic calcium in astrocytes, as compared to tissue treated with NE.  We originally 
hypothesized that CBX would prevent a NE-induced increase in astrocyte cytoplasmic calcium 
similar to the IRL-1620 treated tissue based on previous findings that CBX reduces neural 
activity (Tover et al., 2009) impairs LTP (Chepkova et al., 2008), and decreases diffusion 
of gap junction channel-permeable dye between astrocytes (Sun et al., 2012).  Our data offers a 
possible explanation as to why CBX was unable to significantly decrease the cytoplasmic calcium 
levels in astrocytes. CBX blocks both astrocyte and neuron gap junctions, and our data reveal 
that quinine is able to significantly increase the cytoplasmic calcium levels in astrocytes 
compared to baseline/control readings.  A future experiment of applying both IRL-1620 and 
quinine could clarify if quinine is able to increase the cytoplasmic calcium levels in astrocytes 
while astrocyte gap junctions are closed.  
Another intriguing aspect of our data is that the animals in aim 1 who received CBX 
microinfusions into the PL-mPFC showed a retrieval deficit that was initially very prevalent, but 
turned out to not persist.  Since CBX can block both gap junctions and unopposed hemichannels 
in astrocytes, a possible explanation as to why CBX treated animals showed a strong initial 
retrieval deficit is the CBX treated animals were under similar conditions as the PL-mPFC IRL-
1920 + Gap19 group.  However, since neuron-specific gap junctions are blocked as well with 
CBX, this could explain why the PL-mPFC CBX animals in later trials displayed CPP after controls 
had extinguished, similar to the PL-mPFC quinine-treated animals.  Future experiments 
exploring CBXs long term effects on astrocytes and neurons would help clarify the length of time 
CBX is active and what plasticity triggering events follow. 
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Future Directions 
Gap junctions play a role in learning and memory, emotions and reward-related 
behavior, and even psychiatric and behavioral disorders, but the mechanisms are poorly 
understood. However, investigation of the behavioral impact of gap junctions has revealed that 
pharmacological blockade of gap junctions can impair the acquisition and expression of cued 
fear (Bissiere et al., 2011), bilateral hippocampus blockade of gap junctions with CBX can impair 
rats performance on a water maze (Hosseinzadeh et al., 2005), and post-acquisition infusions of 
the non-selective gap junction blocker 18-alpha-glycyrrhetinic acid can impair retention 
performance in a one-trial discrimination avoidance task in chicks (Verwey and Edwards, 2010). 
I have demonstrated that within the cocaine-associated memory paradigm of a 
conditioned place preference that general or astrocyte gap junction blockade decreases drug-
seeking behavior whereas neuronal gap junction blockade prolongs drug-seeking behavior. Gap 
junction blockade has been theorized to reduce the level of neuronal excitability (Kokarovtseva 
et al., 2013), however whether this is due to astrocytic and neuronal gap junction closure or just 
one specific type remains unclear. Whole cell patch clamp electrophysiology using the either 
IRL-1620 or quinine could determine which specific gap junction type mediates the effects 
observed with a general gap junction blocker such as CBX. Based on my results, I would predict 
that the application of IRL-1620 would decrease neuronal excitability whereas quinine would 
increase neuronal excitability. 
Evidence described here indicates that blocking astrocyte gap junctions prevents an 
increase in calcium levels within astrocytes. Because astrocytes release transmitters in a 
calcium-dependent manner, it would be interesting to see what short and long-term plasticity 
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events can occur within both astrocytes and neurons following prolonged gap junction 
blockade. The blockade of glutamate exchange between astrocytes and neurons increases and 
decreases vesicular glutamate release in pre-synaptic neurons. It also promotes AMPA receptor 
insertion in post-synaptic neurons during withdrawal (Kalivas 2009) but it not known if this is 
dependent on gap junction communication of astrocytes. Electrode recordings of extracellular 
levels of glutamate (Hu et al., 1994) and protein analysis of AMPA receptors (Brown et al., 2002) 
at various time points following IRL-1620 application could determine if astrocyte gap junctions 
influence neuronal plasticity. From the results gathered here, I predict that blocking astrocyte 
gap junctions will decrease extracellular glutamate levels and decrease AMPA receptor levels in 
neurons.  
 
Clinical Relevance 
 Previous work has demonstrated that gap junction dysfunction in the prefrontal cortex 
can induce depressive-like behaviors in rats (Sun et al., 2012). Following chronic unpredictable 
stress, animals exhibited significant decreases in diffusion of gap junction channel-permeable 
dye and expression of Cx43.  However, the cellular and behavioral alterations induced by the 
chronic unpredictable stress were reversed and/or blocked by treatment with the 
antidepressants fluoxetine and duloxetine. Beyond fluoxetine’s SSRI effect on depression, 
fluoxetine also has an anti-depressant effect by increasing expression of the vesicular glutamate 
transporter-1 (VGLUT1) in the PFC (Farley et al., 2012; Chen et al., 2014). However, it is not 
known if VGLUT1 expression is elevated in neurons and/or astrocytes. Therapeutically, targeting 
astrocytes or neurons can create a “chicken or egg” effect concerning which cell influences the 
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other, but further investigation could reveal a greater holistic view of antidepressants on both 
healthy gap junction and synaptic communication. Lastly, previous work from our lab has shown 
that blocking β-adrenergic receptors with specific and non-specific β-adrenergic blockers like 
propranolol or betaxolol can prevent retrieval of a CPP (Otis and Mueller, 2011; Otis et al., 2013, 
2014; Fitzgerald et al., 2016).  It would be interesting to investigate how β-adrenergic blockade 
also influences the communication between astrocyte and neuronal networks because 
astrocytes express a variety of Gq-coupled alpha adrenergic receptors (Cahoy et al., 2008), and 
exogenous norepinephrine triggers a rise in calcium in astrocytes (Salm and McCarthy, 1990) 
that can lead to SNARE-dependent merger of a vesicle membrane with the plasma membrane 
(Vardjan & Zorec, 2015).  
 
Conclusion 
These studies aimed (1) to determine whether gap junction communication is a 
mechanism for memory retrieval and extinction of a cocaine CPP and (2) to evaluate PL-mPFC 
astrocytic calcium levels following general, neuronal, or astrocytic gap junction communication 
blockade. Overall this dissertation provides evidence that both gap junction communication and 
the communication between astrocytes and neurons are both actively involved with memory. 
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